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Summary 
In mice, natural resistance or susceptibility to infection with intracellular parasites is determined 
by a locus or group of loci on chromosome 1, designated Bcg, Lsh, and Ity, which controls early 
microbial replication in reticuloendothelial organs. We have identified by positional cloning a 
candidate gene for Beg, Nrampl, which codes for a novel macrophage-specific membrane trans- 
port protein.  We have created a mouse mutant bearing a null allele at Nrampl,  and we have 
analyzed the effect of such a mutation on natural resistance to infection. Targeted disruption 
of Nrampl  has pleiotropic effects on natural resistance to infection with intracellular parasites, 
as it eliminated resistance to Mycobacterium boris, Leishmania donovani, and lethal Salmonella typhimu- 
rium infection, establishing that Nrampl, Bcg, Lsh, and It), are the same locus. Comparing the 
profiles of parasite replication in control and Nrampl -/-  mice indicated that the NramplAse  169 
allele of Beg  s inbred strains is a null allele, pointing to a critical role of this residue in the mech- 
anism of action of the protein.  Despite their inability to control parasite growth in the early 
nonimmune phase of the infection, Nrampl -/-  mutants can overcome the infection in the late 
immune phase, suggesting that Nrampl  plays a key role only in the early part of the macro- 
phage-parasite interaction and may function by a cytocidal or cytostatic mechanism distinct from 
those expressed by activated macrophages. 
A  better understanding at the molecular level of the host 
/  ]k mechanisms of defense against infection may open new 
therapeutic avenues for intervention in diseases in which drug 
resistance is a major impediment to treatment. The genetic 
analysis in mouse models of natural variations in innate sus- 
ceptibility or resistance to various parasitic,  bacterial, or viral 
infections provides a rational approach to the identification 
and characterization of such mechanisms (for review see ref- 
erence 1). 
One of the best studied genetic determinants of natural 
resistance or susceptibility to infectious diseases is the Bcg 
gene (2). Bcg is a single gene that is present in two allelic 
forms in the mouse (resistant, Bcg  r, and susceptible, Beg  ~) and 
determines innate resistance/susceptibility of mice to infec- 
tion with several mycobacterial species such as Mycobacteriurn 
bov/s (bacille  Calmette-Guerin  [BCG]I),  M.  lepraemurium, 
1 Abbreviations used in this paper: BCG, baciUe Calmette-Guerin; ES, em- 
bryonic stem; LDU, Leishman-Donovan units; mRNA, messenger RNA; 
P/L, phagosome/lysosome;  TM, transmembrane. 
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and M. intracellulare  (2-4). In inbred mouse strains,  infection 
with M. bovis (BCG) is biphasic, with an early nonimmune 
phase (0-3 wk) characterized either by rapid proliferation of 
the bacteria in reticuloendothelial (RE) organs (liver, spleen) 
of Beg  s,  or by absence of bacterial growth in Bcg  r mouse 
strains (2). The late phase (3-6 wk), characterized either by 
complete clearance of the bacterial load or by persistent in- 
fection in the RE organs of the susceptible strains,  is con- 
trolled by H-2-1inked immune response genes (5, 6). Genetic 
linkage studies have shown that Bcg is either aUelic or very 
tightly linked to two other host resistance loci, Lsh (7) and 
Ity (8). Similar to Bcg, Lsh controls the replication of Leish- 
mania donovani in the RE organs, early in the nonimmune 
phase of infection (7). Ity also influences the early replication 
of Salmonella typhimurium in RE organs, but in this case animals 
either survive (resistant; Ity') or succumb rapidly (susceptible; 
Ity  ~) to an infectious inoculum (8),  In vitro (9-11)  and in 
vivo (12-14)  studies have shown that Beg, Ity, and Lsh affect 
the capacity of the macrophage to  restrict the intracellu- 
lar replication of these antigenically unrelated intracellular 
parasites. 
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for Bcg. This approach was based on the construction of high 
resolution linkage (15) and physical maps (16) of the Bcg re- 
gion on mouse chromosome 1, and on the isolation and char- 
acterization of cloned segments of the minimal physical in- 
terval in YAC clones  (17). Briefly, exon trapping was used 
to identify seven candidate transcription units for Bcg. Of these 
genes, two were ubiquitously expressed in all tissues including 
RE organs, while one encoded a messenger RNA (mRNA) 
exclusively expressed in RE organs and, most importantly, 
in macrophages derived from them (17). This gene, desig- 
nated Nramp (natural resistance-associated  macrophage pro- 
tein) encoded a novel integral membrane protein with 12 puta- 
tive transmembrane (TM) domains, a glycosylated extraceUular 
loop, and several phosphorylation sites (17). In addition, Nramp 
shares, through the presence of a consensus sequence signa- 
ture, homology to a number of eukaryotic and prokaryotic 
membrane transport proteins, including a nitrate/nitrite con- 
centrator of the fungus Aspergillus nidulans (18). Therefore, 
Nramp seems to be a novel macrophage-specific transport pro- 
tein. Recently, we have determined that Nramp is part of a 
small gene family of at least two genes in the mouse, with 
a second gene Nramp2 on chromosome 15 (19), and we have 
consequently renamed the chromosome 1 locus Nrampl (19). 
Since the Bcgs and Beg' genotypes and phenotypic char- 
acteristics are not unique to a specific mutant strain, but rather 
separate inbred strains in two nonoverlapping groups, we have 
analyzed a total of 27 Bcg' and Bcg' mouse strains for nucleo- 
tide sequence variations within the coding portion of Nrampl 
(20).  One G  to A  substitution at nucleotide position 596 
resulting in the nonconservative replacement of Gly  169 to 
Asp 169 within TM4 was found to be in absolute association 
with the Beg phenotype in 20 Bcg  r strains (Gly  169) and 7 Bcg' 
strains  (Asp 169) tested (20).  Haplotype mapping using se- 
quence polymorphism identified within Nrampl  and 11 ad- 
ditional polymorphic markers from the region revealed that 
the 7 Bcg  ~ strains tested shared  a conserved core haplotype 
of 2.2 Mb overlapping Nrampl  (20). 
Although the replacement of a small neutral residue (gly- 
cine) by a bulkier, negatively charged one (aspartate) within 
one of the predicted TM domains of Nramp1 would be likely 
to affect function, it does not per se constitute an obvious 
loss of function, and a full-length polypeptide is expected 
to be synthesized in Bcgs mice. Therefore,  we have used gene 
targeting to create a null allele at the Nramp1 locus with the 
intent (a) to determine if Nramp1 and Bcg are indeed allelic; 
(b)  to determine if Bcg, Lsh,  and Ity are allelic;  and (c)  to 
compare  the  phenotypic  expression  of NrarnplAsp  169  and 
NrampI  null mutations. 
Materials and Methods 
Design of Targeting Vector.  The targeting vector pMC.NR was 
derived from the plasmid pMClneo-polyA  and the Nrampl genomic 
clone Xnrp1. pMClneo-polyA (Stratagene, La Jolla, CA) contains 
a 1-kb cassette with the structural neomycin resistance gene (neo) 
under the control of the Herpes simplex thymidine kinase (HSV- 
tle) gene promoter and followed at its 3' end by a polyadenylation 
signal. The genomic DNA clone Xnrpl (Gros, P., and G. Govoni, 
unpublished data) was isolated from a 129sv/J mouse genomic li- 
brary constructed in bacteriophage vector XDASH (Stratagene). 
It contains a 17-kb DNA insert overlapping exons 3-15 from the 
Nramp1 gene. The longer genomic arm of pMC.NR was a 5-kb 
Nrampl fragment from intron 8 to within exon 15 cloned into the 
BamHI site of pMClneo-poly(A). The shorter genomic arm of 
pMC.NR was a 1.1-kb SalI to HindlII Nramp1 fragment extending 
from intron 4 to within exon 7. The cohesive ends of the 1.1-kb 
fragment were repaired with T4 DNA polymerase  before ligation 
into the blunted XhoI site of the vector. The short Nramt,1 genomic 
arm provides a unique NotI site that originates from the polylinker 
of the hi)ASH vector. The two Nramp1 genomic fragments were 
cloned so that their transcriptional  orientation was the same as that 
of the neo cassette. Before transfection into embryonic stem (ES) 
cells, the construct was linearized by Nod digestion and dissolved 
in sterile water. 
ES Cell Culture and Electroporation.  The 129sv ES cell line J1 
(21) was seeded  onto a mitomycin  C (Sigma  Chemical  Co., St. Louis, 
MO)-inactivated embryonic  fibroblast  feeder  cell layer  (2 h at 37~ 
in DMEM (GIBCO BILL,  Gaithersburg, MD) containing  500 U/rnl 
leukemia inhibitory factor (GIBCO BILL)  and 15% heat-inactivated 
FCS (GIBCO BILL).  For electroporation, ES cells were trypsinized 
and resuspended (107 cells/ml) in PBS. 1 ml of the cell suspension 
was mixed with pMC.NR-linearized DNA at a concentration of 
50/~g/ml and electroporated  using a Gene Pulser (Bio-Rad Labora- 
tories, Richmond, CA) with a setting of 500/~F capacitance, 240 
mV (22). ES cells were then plated at a density of 2  ￿  105 cells 
per 60-mm dish onto a monolayer of neomycin-resistant, mitoti- 
cally inactive fibroblast feeder cells. Selection for neo + clones was 
initiated 24 h later by addition of geneticin (G418; GIBCO BRL; 
final concentration 500/~g/ml).  5-10 G418  R colonies per plate 
were picked 10 d after electroporation and sequentially expanded 
in 96- and 24-well titer plates. Each clone was recovered  by trypsin 
treatment  and then frozen at  -80~  in culture medium sup- 
plemented with 10% DMSO and 20% FCS. 
Genotyping of ES Cell Lines and Mutant Mice.  Genomic  DNA 
from individual ES clones was directly isolated onto replica 96-well 
plates according to the procedure of Ramirez-Solis et al. (23), dis- 
solved in 30/A of restriction enzyme buffer (recommended  by the 
supplier of enzyme) containing 1 mM spermidine and 100/~g/ml 
BSA, and digested with 20 U of either BamHI or XbaI (incuba- 
tion 16 h, 37~  Genomic DNA was isolated from mouse tails 
by a standard protocol (24) using proteinase K digestion, phenol 
extraction, and ethanol precipitation. Restricted DNA from ES 
cell clones or mouse tails was resolved by electrophoresis in 1% 
agarose gels containing TAE buffer (40 mM Tris-acetate, 20 mM 
sodium acetate, 20 mM EDTA, pH 7.6), and transferred  onto nylon 
membranes (Hybond-N; Amersham International, Little Chalfont, 
UK) by capillary blotting in 20x  SSC (lx  SSC is 0.15 M NaC1, 
0.015 M sodium citrate). Southern blots were prehybridized for 
16 h at 42~  and then hybridized for 16 h at 42~  in the same 
mixture composed of 50% formamide, 5x  SSC, 1% SDS, 10% 
dextran sulfate, 20 mM Tris-HC1, pH 7.5, lx Denhardt's solution 
(0.1% BSA, 0.1% Ficoll, 0.1% polyvinylpyrrolidone), and heat- 
denatured salmon  sperm DNA at a final  concentration  of  200/~g/ml. 
The Nrampl hybridization probe was a cDNA fragment (nucleo- 
tide 300 to 550; 17) labeled to high  specific activity (1  x  109 
cpm//xg  DNA)  by  random  priming  (25) with  cr 
(specific activity 3,000 Ci/mmole), and used at 1 x  106 cpm/ml 
of hybridization solution. The membranes were washed to a final 
stringency of 0.5x  SSC, 0.1% SDS at 65~  for 30 min. 
Blastocyst  Injection and Animal  Breeding.  Blastocysts  were obtained 
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by natural mating with syngeneic males. 10--15 ES cells from two 
independent clones, EPl-26 and EP2-173, were microinjected into 
each blastocoel cavity (26). The blastocysts  were then reimplanted 
into the uterine horn of pseudopregnant CD1  mice. Chimeric 
offspring were identified by the agouti contribution of the ES cells 
to the coat color, and chimeric males were crossed with BALB/c 
females to produce a (129sv x BALB/c)  F1 generation bearing one 
Nrarnpl null allele (NrarnpI -/A~16~). Germline transmission  was de- 
termined by the presence of agouti mice in the offspring.  The geno- 
type  of  this  offspring  was  determined  by  tail  blot,  and 
Nrampl -/Asp~s~  carrier animals were either backcrossed to BALB/c 
animals to expand the heterozygous Nrampl-/A,r16~  population or 
intercrossed  to  generate  homozygous  F2  null  mutant  mice 
(Nrampl-/-).  Mutant F1  (Nrampl-/A~r  16~) and F2 (Nrampl -/-) 
animals were genotyped and then tested for susceptibility to infec- 
tion with intracellular parasites. 
RNA Hybn'dization Studies.  Total  cellular KNA was isolated 
from frozen spleens after homogenization with a mortar and pestle 
precooled with liquid nitrogen. The tissue powder was dissolved 
in guanidinium hydrochloride (6 M), and KNA was recovered by 
differential ethanol precipitation and phenol and chloroform ex- 
tractions (27). KNA was separated by electrophoresis in a dena- 
turing formaldehyde  agarose gel and transferred to a nylon mem- 
brane (GeneScreen Plus, E. I. du Pont de Nemours & Co., Inc., 
Wilmington, DE), and the blot was prehybridized (16 h, 65~ 
and hybridized (16 h, 65~  in the same solution consisting of 1 M 
NaC1, 1% SDS, and 10% dextran sulfate. The hybridization probe 
was a mouse Nrampl cDNA subfragment overlapping exons 7 and 
8 (nudeotide 855-1064; 17), was labeled to high specific activity 
with oI-[3zp]dATP, and was used at 2  x  106 cpm/ml hybridiza- 
tion solution. The blot was washed under conditions of increasing 
stringency up to 0.5x  SSC, 0.1% SDS at 65~  for 45 min. 
Infection of  Mice with BCG, L. donovani, andS. typhimurium.  The 
BCG infectious inoculum consisted of a single-ceLl suspension of 
M. boris (BCG, strain Montreal) prepared by microfiltration from 
two serial 7-d cultures in Dubos oleic acid medium, as previously 
described (2). Mice were inoculated in the caudal tail vein with 
0.25 ml of a BCG suspension containing 1.4  x  104 CFU/ml in 
physiological  saline. The degree of infection was assessed  by deter- 
mining the number of spleen colony-forming  units at predetermined 
time intervals (2). Geometric means plus or minus standard devia- 
tion of  spleen BCG CFUs were calcuhted from five  infected  animals 
per time point. 
The virulent strain L. donovani  infantum Ethiopian LV9 was pas- 
saged continuously by intraperitoneal infection of Syrian hamsters 
and was generously donated by Dr. G. Matlashewski (Institute of 
Parasitology,  McGill University,  Montreal, Canada). The infectious 
inoculum was prepared from spleen homogenates of infected ham- 
sters according to the procedure of Murray et al. (28) and used 
immediately to infect mice intravenously (caudal tail vein, 0.2 ml 
volume of a  suspension of 5  x  107/ml infectious L.  donovani 
amastigotes). At different times (1, 3, and 6 wk) after infection, 
livers were removed, weighed, and sectioned  for impression smears. 
The extent of disease was quantitated by microscopic determina- 
tion of the number of parasites in Giemsa-stained  liver impression 
smears. Hepatic  parasite burden was expressed  in Leishman-Donovan 
units (LDU, the number of parasites per 1,000 nucleated cells x 
liver weight in milligrams; 28). A minimum of four mice were 
used for each infection time point and for each experimental  group. 
The highly virulent S. typhimurium strain KeUer (29) was origi- 
nally obtained from Dr. Hugh Robson (Royal Victoria Hospital, 
Montreal, Canada). Mice were injected intravenously (caudal tail 
vein) with a 0.2-ml inoculum containing 5  x  104 CFU/ml S. ty- 
phimurium. Animals were examined twice a day for a period of up 
to 4 wk, and deaths were recorded and moribund animals were 
kiUed. Resistance to infection was assessed by the percentage of 
surviving animals among groups of 5-15 mice. It)~ animals typi- 
cally succumbed to infection within 4-6 d, while lty' animals typi- 
cally survived at least 14 d after infection. 
Histopathology.  Mice  from various groups were killed by cer- 
vical dislocation  and autopsied. The major organs, including spleen, 
liver, lung, intestine, colon, and thymus, were removed, immedi- 
ately fixed in 10% formalin, and embedded in paraffin. Sections 
(5 #m) from paraffin  blocks containing these organs were stained 
with hematoxylin and eosin for routine histological examination. 
Randomly selected (n  =  10) high power fields (x 100 and  x 160) 
of tissue sections were examined from each animal. In addition, 
5-#m sections of the spleen and liver were stained for the presence 
of mycobacteria by the Ziehl-Neelsen acid-fast stain. 
Results 
Disruption of the NrarnpICIr  169 Allele Associated with Resis- 
tance to Infection with lntracellular Parasites.  We used homol- 
ogous recombination in ES calls to generate a mutant mouse 
carrying a null allele at the Nrarapl  locus (NrampI -) on the 
Bcg  r genetic background of the ES  cell  line J1  (21) from 
mouse strain 129sv (Beg  r, NramplClY  169, or Nrampl +). Since 
the resistance Beg' aUele is dominant over the susceptibility 
Bcg  s allele, the loss of resistance  to infection after targeting 
of the NramplClY  169  aUele associated  with  resistance  (20) 
should unambiguously confirm that Nrampl and Bcg are the 
same  gen~  Our  targeting strategy was based  on that of 
Thomas and Capecchi (30) and used neo as a positive selec- 
table marker. To construct the targeting vector pMC.NR, 
two noncontiguous Nrampl  genomic fragments of size 1.1 
kb (exons 5-7) and 5.0 kb (exons 9-15) were cloned into the 
plasmid pMClneo-polyA on either side of the neo cassette (Fig. 
1). Successful targeting of the NrarapI locus by homologous 
recombination using this construct should result in (a) dele- 
tion of a 500-bp Nrarapl  genomic DNA segment disrupting 
exon 7 and ddeting exon 8; (b) insertion of the neo marker 
at that site and introduction of translation termination codons 
in three reading frames, resulting in a severely truncated pro- 
rein lacking 8 of the 12 predicted TM domains; and (c) gener- 
ation of novel RFLPs diagnostic for the targeted event. 
Successful targeting of Nrampl was identified  by Southern 
blotting of genomic DNA through the appearance of diag- 
nostic 6.0-kb BamHI or 8.5-kb XbaI fragments hybridizing 
to an Nrampl cDNA probe (nucleotide 300-550;  17) external 
to the targeting construct. An example of this analysis is shown 
in Fig.  1 B in which the hybridization profiles  of targeted 
and nontargeted (2-62) ES clones are compared. Two inde- 
pendent ES clones, 1-26 and 2-173, were used to produce chi- 
meric mice by injection into expanded BALB/c blastocysts. 
Male chimeras were mated to  BALB/c (NrampIAsr  169) fe- 
males, and the F1 progeny scored for successful germline trans- 
mission of the targeted Nrarapl  allele (agouti color). Since 
the Beg' alhle is dominant, the appearance of animals suscep- 
tible to infection in heterozygous carriers  (Nrampl-/Asp169) 
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Nramp1 locus is shown with the genomic exons numbered 1-15 and identified as dark boxes (wild-type allele). A diagram of the Nrampl-targeting 
vector showing the neo expression cassette flanked by a proximal 1.1-kb fragment that includes exons 5 and 6 and part of exon 7 on one side, and 
a 5.0-kb fragment that includes exons 9-15 on the other side, is shown below the wild-type allele  map. The genomic organization of the corresponding 
mutant allele  generated by successful  homologous recombination at Nramp1 in ES cells is presented. Restriction enzymes sites for BamHI (B), EcoRI 
(E), HindlII (H), and Xbal (X) are identified in both alleles. The position of key genomic XbaI and BamHl restriction DNA fragments diagnostic 
of the wild-type (7.0-kb XbaI, 5.5-kb BamHI) and the mutant Nramlsl allele (8.5-kb Xbal, 6.0-kb BamHI) targeted by homologous recombination 
and recognized by a cDNA hybridization probe overlapping exons 3-4 (positions 300-550; 17) are indicated immediately above and below the corre- 
sponding genomic maps of the two alleles. (13)  Nramp1 targeting in ES cells. Results of Southern blotting analysis of genomic DNA from independent 
G418-resistant ES cell clones digested with either BamHI or Xbal and hybridized to a Nrampl cDNA fragment (positions 300-550; 17) are shown. 
Successful targeting is evidenced  for clones 1-25, 2-65, 2-110, 2-161, and 2-172 by the presence  of diagnostic 6-kb BamHI- and 8.5-kb Xbal-hybridizing 
fragments on the background of the endogenous 5.5-kb BamHI and 7.0-kb XbaI fragments. (C) Creation Nrampl mutant mice. Results of Southern 
blotting analysis of genomic DNA from control 129sv mouse strain and individuals from a (129sv x  BALB/c)  F2 cross in which the wild-type allele 
of 129sv  had been successfully  targeted  by homologous recombination  are shown. Offspring  from this cross  include  heterozygotes  (-/+) and homozygotes 
(-/-) for the targeted allele Nramp1-. The Nrampl cDNA probe and diagnostic hybridizing restriction fragments are as described in/~ 
would  demonstrate  allelism  between  Nrampl and  Beg. 
Homozygous null mutants  (Nrampl-/-)  were obtained by 
intercrossing independently heterozygotes derived from ei- 
ther  1-26  or 2-173  ES cell clones,  and  the null Nrampl-/- 
genotype  was  verified  by  Southern  blotting  (Fig.  1  C). 
Homozygous Nrampl-/-  null mice were housed  in  a bar- 
rier facility and were free of specific mouse pathogens. Under 
these  conditions,  the  general  health  and  viability  of 
Nrampl -/-  mice appeared  normal  up  to  14  mo  of age. 
Wild-type Nramp1 mRNA  Transcripts Are  Absent from 
Nrampl -/- Null Mice.  To verify that intact Nrampl mRNA 
was indeed absent from mutant mice, Northern blotting anal- 
ysis of total spleen RNA from wild-type, heterozygous, and 
homozygous mutant mice was carried out using a hybridiza- 
tion probe corresponding to exons 7 and 8 of the gene, which 
are deleted by the targeting event (nucleotide 855-1064;  17) 
(Fig. 2 A). The spleen was chosen as a source of RNA since 
it  is  the  strongest  site of endogenous Nrampl mRNA  ex- 
pression in normal mouse tissues (17). Results from this anal- 
ysis (Fig. 2 A) indicated that the 2.4-kb Nrampl mRNA was 
abundant in spleen from wild-type animals and that its level 
was  reduced  by  ~50%  in  heterozygotes  (Nrampl -/+ ), 
whereas  it  could  not  be  detected  in  homozygous  null 
(Nrampl-/-)  mice,  even  upon  prolonged  exposure  of the 
blot (data not shown). The reduction in or absence of Nrampl 
mRNA detected by Northern blotting with this probe was 
not due to absence of RNA in the lanes, since reprobing of 
the blot with a control GAPDH cDNA probe revealed equal 
RNA loading and transfer to the membrane in each lane (Fig. 
2 C). These results indicate that no wild-type Nrampl mRNA 
transcripts  are produced in homozygous null mutants.  Re- 
hybridization of the blot with a neo gene probe or a probe 
corresponding to exon 5 of Nrampl revealed the presence of 
several novel mRNAs that were specific to the targeted gene 
and were absent from spleens of control BALB/c mice (Fig. 
2 B  and data not  shown).  These transcripts  most likely ei- 
ther represent hybrid neo-Nrampl mRNAs or result from al- 
ternative splicing of the neo cassette in the targeted gene. How- 
ever, either event would result in the production of RNAs 
recruiting different reading frames, resulting in the appear- 
ance of termination codon within exon 9, producing a ma- 
ture Nrampl  protein that is severely truncated  (lacking the 
carboxy-terminal half)  and  probably  nonfunctional. 
Organ  Morphology of Nrampl -/-  Null  Mice.  Mouse 
Nrampl is expressed primarily in macrophages,  professional 
phagocytic cells which populate all tissues of the host. These 
658  The Ity/Lsh/Bcg Locus Figure  2.  Absence  of  wild-type  Nramp1  mRNA transcripts  in targeted 
mice. 20/zg of total cellular  RNA from spleen of control BALB/cJ, con- 
tro! (129sv x BALB/cJ)  F1 mice, and animals from a (129sv x BALB/c) 
F2  cross, either heterozygous (Nrarnlol-/A'p169) or  homozygous 
(Nrarapl-/-) for a null allele at Nrarapl,  was separated  by agarose  gel elec- 
trophoresis  and analyzed  by Northern  blotting. (A) The hybridization  probe 
corresponds to a portion of Nrara_pl exons 7 and 8 that is deleted  by ho- 
mologous recombination  at the Nrarapl locus, using  the targeting  vector 
described  in Fig. 1 A. The 2.4-kb Nrampl mtLNA  transcript  is identified 
in control groups and in the heterozygous  null mutant. The same  blot 
was rehybridized  to control cDNA probes corresponding  either to the 
neo gene  probe  present  in the targeting  vector  (B) or to the cellular  glycer- 
aldehyde phosphate dehydrogenase  gene (C). 
cells not only play a key role as a first line of defense against 
intracellular parasites but also participate in other key physi- 
ological events such as adaptive immune response and normal 
development  of certain  organs  and  structures.  Although 
homozygous Nramlol-/-  null mice were viable and fertile, 
we analyzed possible  deleterious effects of the  absence of 
Nrampl  on organ morphogenesis. Special attention was paid 
to the macrophage-rich RE organs, spleen and liver. The white 
and red pulp (Fig.  3, panel I ) regions were well defined in 
the spleen of control and Nramp1 -/- mutants, and distribu- 
tion of specific cell populations within these regions was also 
preserved. Darkly stained cells are lymphocytes within the 
dense lymphoid tissues  of the white pulp organized around 
small arterioles (Fig. 3, panel 2), whereas weakly stained cells 
are macrophages,  dendritic cells,  sparse  lymphocytes, and 
plasma cells  scattered among vascular sinusoids,  which to- 
gether constitute the red pulp. Likewise, the normal architec- 
ture of the liver was maintained in Nrampl -/- animals (Fig. 
3, panel 3).  Liver lobules show regular trabecular arrange- 
ment of hepatocytes of uniform size  with hepatic macrophages, 
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or Kupffer cells, lining the sinusoidal space (data not shown). 
Fig.  3, panels 4-7,  presents an analysis  in Nrampl-/-  mu- 
tants of other tissues that are not classified as RE organs but 
nevertheless  contain  biochemically  and  immunologically 
unique populations of macrophages. These include lung pa- 
renchyma (Fig.  3, panel 4), thymus (Fig.  3, panel 6), small 
intestine (Fig. 3, panel 5), and colon (Fig.  3, panel 7). The 
integrity of these structures and cell populations  was also found 
to be intact in Nrampl-/-  mutant mice. 
Disruption of the NramlolCly  169 Allele Abrogates Resistance to 
BCG Infection.  In mice,  BCG  infection in  RE  organs  is 
biphasic,  with an early phase (up to 3 wk) that is under Bcg 
gene control and is characterized by either rapid bacterial repli- 
cation  in  Bcg  s mice  or  no  bacterial  proliferation  in  Bcg  r 
animals. The late or immune phase of infection is character- 
ized by bacterial  clearance from  the  spleen  of Bcg  ~ mice, 
through the emergence of specific T  cell-mediated immu- 
nity and bacillary destruction by activated macrophages. To 
assess the role of Nrampl  in resistance to mycobacterial in- 
fections, the kinetics of BCG infection was followed in the 
spleen of either resistant control (129sv  x  BALB/c) F1 mice 
(Nrampl +/a~v169),  susceptible control BALB/c (NramplA~p  169) 
mice,  or  mice  heterozygous  for  a  null  allele  at  Nrampl 
(Nrampl -/A,r169). In control BALB/c mice, bacterial prolifer- 
ation was rapid and uncontrolled in the early phase and reached 
a maximum at 3 wk (1.5  x  10  s BCG CFU/spleen), and the 
BCG load was decreased by 6 wk after infection (Fig. 4 B). 
On the other hand, in control resistant (129sv  x  BALB/c) 
F1 animals, little or no bacterial proliferation was observed 
in the spleen at  any time during infection (maximal load, 
3  x  103 CFU BCGApleen) (Fig. 4 A). The profile of BCG 
infection in (129sv  x  BALB/c) F1 mice heterozygous for the 
null allele (Nrampl-/.~t,169) (Fig. 4 C) was indistinguishable 
from that of BALB/c control (Fig. 4 B), including rapid early 
BCG proliferation peaking at 3 wk (1.5  x  l0  s CFU BCG/ 
spleen), followed by progressive elimination of the bacterial 
load.  These  results  show  that  mice  carrying  a  mutated 
NramplCtr  169 allele  (Nrampl-/Asei69) lose  their  capacity  to 
control BCG growth when compared with their littermates 
carrying the unmutated allele (Nrampl +/A,p169),  and they es- 
tablish  that Nrampl  and Beg are allelic. 
BALB/c  mice  (Bcgs, NrampIA'e  169) can  mount  efficient 
immune response and ultimately eradicate the spleen bacterial 
load (Fig.  4 B) in the late phase of infection, through a T 
cell--dependent macrophage activation process (31, 32). Should 
NrampI also play a role in macrophage--mediated  BCG killing 
in the late phase of infection, these observations suggest that 
the NramplAsp  169 allele may only constitute a partial loss of 
function. Results shown in Fig.  4 indicate that the kinetics 
of BCG infection in homozygous Nrampl-/-  mice (Fig.  4 
D) was identical to that of BALB/c controls (Fig. 4 B) and 
of Nrampl-/Ase  169 heterozygotes (Fig.  4  C),  strongly sug- 
gesting that the NrampIA'e  ~69 allele of Bcgs mice is as severe 
a mutation as the Nrampl-  allele. 
Interestingly, data in Fig. 4 D  also indicate that homozy- 
gous null mutants are able to  stop BCG proliferation and 
initiate bacterial clearance in the late phase of  infection. During 
this part of the BCG infection, infected macrophages syn- F
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Figure  4.  BCG infection  in spleens of control mice and mice  bearing 
targeted mutations  at NrampI. Groups of either control resistant (1295v 
x BALB/cJ)  F1 (+/Aspt69, A) or susceptible BALB/cJ  mice (Asp169, 
B), and mice from a (1295v x  BALB/cJ)  F2 cross either heterozygous 
(-/Asp169, C) or homozygous  (-/-, D) for a null allele  at Nrampl were 
tested for resistance to infection  with M. bovis (BCG). 2 x 104 live  BCG 
bacilli were  injected  intravenously,  and the number  of  live  colony-forming 
units of BCG recovered from infected  spleen was determined  at different 
times after  infection  ~i.). Results  from  individual  groups of five  mice  were 
pooled, and the logarithm  of the average  number  of colony-forming  units 
(+_  standard  errors) was calculated and is shown. 
thesize cytokines, leading to T  cell  activation and further 
recruitment of monocytes to form granulomas, the primary 
site of infection, and, eventually, bacterial eradication in RE 
organs (immune phase).  To analyze more closely this aspect 
of BCG infection in Nrarnp1-/-  mice, a histological anal- 
ysis of  infected RE organs was carried out. All aspects of gran- 
uloma formation were found to be identical in Nramp1-l- 
and control BALB/c mice, with respect to site, number, mor- 
phology, and cell populations involved (Fig. 3). Granuloma 
formation was restricted to the spleen and liver of  both groups 
of mice; a few small granulomas were detected as early as 
2 wk (data not shown), while at 3 wk their number and 
size were maximal. Well-formed granulomas are shown for 
the spleen (Fig. 3, panels 9 and 10) and liver (Fig. 3, panels 
12 and 13) and consist of large epitheloid cells (differentiated 
macrophages) and monocytes, arranged in a whirling and 
palisading pattern. Staining of these structures for acid-fast 
bacilli (Ziehl-Neelsen) revealed the presence  of BCG bacilli 
within these granulomas in spleen and liver (Fig.  3, panels 
11  and  14,  respectively).  In both Nrampl-/-  and control 
BALB/c mice, the number and size of granulomas had declined 
considerably by 6 wk after infection (data not shown). These 
results indicate that an intact Nrampl  gene is not necessary 
to (a) mount cellular responses against BCG leading to granu- 
loma formation; (b) contain bacterial dissemination; or (c) 
trigger macrophage differentiation  into cells capable of killing 
ingested mycobacteria. 
Disruption of the NramplCly 169 Allele Has Pleiotropic Effects 
on Resistance to Intracellular Infections.  Genetic linkage studies 
have indicated that Beg is tightly linked to two other host 
resistance loci, Lsh and It), (33), which control natural resis- 
tance of mice to infection with L. donovani and S. typhimu- 
rium, respectively (7, 8). To determine ifBcg/Ity/Lsh  are the 
same gene, we tested the effect of a null mutation at Nrampl 
on resistance  to L.  donovani and S.  typhimurium. 
To assess the role of Nrampl in resistance to L. donovani, the 
kinetics of L. donovani infection was followed in the liver of 
either resistant control (1295v x  BALB/c) F1 (Nrampl +/.~.~169) 
mice, susceptible  control BALB/c (NramplA~P  169) mice,  or 
mice  heterozygous  for  a  null  mutation  at  Nrampl 
(Nrampl-/A~p169) (Fig. 5). In control BALB/c mice, L. dono- 
vani replication was rapid during the early phase and reached 
a maximum at 3 wk (average 1,400 LDU), and parasite counts 
had decreased by '~50% by 6 wk after injection (average 750 
LDU) (Fig. 5 A). By contrast, little or no parasite prolifera- 
tion was observed  in the liver of control resistant (129sv  x 
BALB/c) F1 animals throughout the 6-wk observation period 
(average 80 LDU at 1 wk versus  120 LDU at 6 wk) (Fig. 
5 B). Results shown in Fig. 5 C show that in the heterozy- 
i 
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|  . 
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2500" 
2000. 
1500' 
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500 
0 
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c 
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2OOO 
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1000, 
S00.  |  I 
I  ￿9  l  I 
!  !  :  :  =  0  !  I  l  I  I  I 
2  3  4  s  e  o  ~  2  3  4  s  e 
weeks  p.i.  weeks  p.i. 
(-/Asp 169)  ￿9 
Figure 5.  L. donovani  infection in 
livers of control mice and mice 
bearing  targeted  mutations at 
Nrampl. Groups of either control 
susceptible  BALB/cJ  mice  (Asp169, 
A) or resistant (129sv x BALB/cJ) 
F1 (+/Asp169, B) mice, and mice 
from a (1295v x BALB/cJ)  F2 cross 
heterozygous  (-/Asp169, C) for a 
null allele at Nrarap1, were tested 
for  resistance to  infection with 
L. donovani. 1 x  107 live L. dono- 
vani amastigotes  were injected in- 
travenously,  and the parasitemia  was 
followed  in the liver  by determining 
the  number  of  LDU  (num- 
ber of amastigotes/1,000 scored cell nuclei) in fresh imprints of this organ at different  times after  infection  (Fi.). The results from individual  animals 
of groups of three to five mice are shown. 
661  Vidal et al. gotes (129sv  x  BALB/c) F1 mutants (Nrampl-/A,p169), the  A 
profile of L. donovani infection was very similar to that ob- 
served in BALB/c controls (Fig.  5 A), including rapid para- 
site proliferation in the early phase peaking at 3 wk, followed 
by a reduction in the liver parasite load by 6 wk after infec-  0~ 
tion. These results clearly indicate that disruption of Nrampl 
abrogates natural resistance to L. donovani  infection, demon- 
strating  that Lsh  and Nrampl  are  the same gene. 
As opposed to infections with mycobacteria or L. donovani,  ,oo 
S. typhimurium  is a highly virulent mouse pathogen that repli-  8o 
cates very rapidly in RE organs and produces an overwhelming 
and rapidly lethal infection in susceptible mouse strains (8).  ~0 
Other inbred mouse strains are completely resistant and sur-  ,o 
vive an infectious challenge well. In this infection, the differen-  2o 
tial growth of the microbe in the early phase of the infection  0 
is critical for survival of the animals,  since the infection is 
rapid and does not allow for the establishment of specific im-  c  100 
mune response as with the other two infectious models ana- 
lyzed.  The dramatic  difference in bacterial growth rates  is  ~  ,0 
genetically controlled by the Ity gene, which maps very closely 
to or is identical  to Lsh  and Bcg. 
Since the Ity phenotype of the  129sv  strain  used in  the 
targeting  experiment  was unknown,  and  since  additional  0 
genetic loci can also modulate early replication  of S. typhi- 
murium in RE organs (see Discussion), we compared the de- 
gree of resistance/susceptibility to this infection of control 
C57BI/6J and BALB/cJ mice (both Ity  ~, NramlolA~  169) with 
that of (129sv  x  BALB/c) F1 hybrids (Itff  s, Nrampl +/A~169). 
Results in Fig. 6 (experiment A) show that control C57BL/6J 
and BALB/c mice quickly succumbed to this infectious in- 
oculum, with no animal from these two groups surviving more 
than 6 d. In contrast, all (129sv  x  BALB/c) F1 animals  sur- 
vived this period and were still healthy 2 wk after infection 
(end of observation period).  This indicated that  129sv mice 
carry the Ity  ~ allele, in  agreement with previous haplotype- 
typing data (20).  Results from experiment B in Fig.  6 indi- 
cated that disruption of the wild-type 129sv Nrampl allele in 
(129sv  x  BALB/c) F1 mice (Nramp1-/~169) abrogated their 
resistance  to S. typhimurium infection, and all animals  of this 
group quickly succumbed to infection within a time span iden- 
tical to that observed in susceptible BALB/c controls. Finally, 
analysis of resistance  to infection in homozygous Nrampl -l- 
mutants in a third experiment (Fig. 6 C) also indicated acute 
sensitivity to S. typhimurium infection. These results establish 
that Nrampl  and It), are allelic. 
Discussion 
Nrampl  and Bcg Are Allelic.  Nrampl  was identified as a 
likely candidate for Bcg (17) as a result of the following ob- 
servations:  (a)  It mapped  within  the minimal  genetic and 
physical intervals delineating  the Beg region;  (b) it was ex- 
pressed primarily in RE organs and macrophages; (c) a non- 
conservative glycine to aspartic  acid substitution  (G169D) 
within TM4 of the protein cosegregated with the Bcg'/Bcg' 
phenotype  in 27 inbred  strains  analyzed  (20);  and  (d)  the 
G169D substitution fell within a region and at a residue highly 
i I  o  .... 
1  3 
F  I (129SvXBALB/c) 
(+/Asp169) 
I  C67BL~ 
(.,~ple9) 
/ 
7  9  11  13  r  p.I. 
(§ 
A~olo9) 
I  3  5  7  9  11  13  days  p.l. 
(+/Aaole0) 
(-I-) 
J 
￿9  ~  '  ~  '  fl  ;3  ~oy, p.~. 
Figure  6.  S. ty?himurium  infection in control mice and mice bearing 
targeted mutations at Nrara?l.  Groups of either control susceptible  BALB/cJ 
and C57BL/6J or control resistant (129sv x BALB/cJ)  F1 mice, or mice 
from a (129sv x BALB/cJ)  F2 cross either heterozygous (-/Asp169) or 
homozygous (-/-) for a null allele at Nrampl, were tested for resistance 
to infection with S. typhimurium  in three separate experiments (numbered 
A-C). 1 ￿  104 live S. typhimurium  bacilli (CFU) were injected intrave- 
nously into groups of 5-15 mice, and animals either moribund or suc- 
cumbing to infection were recorded twice a day. The data are expressed 
as the proportion of animals surviving the infection and are shown as the 
percentage of survival. 
conserved across Nramp homologues of other species  (17, 20). 
Despite this evidence, the association between Nramp1 and 
Beg remained correlative,  and logical counterarguments could 
be put forward:  (a)  The minimal  physical interval for Beg 
was estimated at  1.1 Mb, and only a 400-kb portion  of it 
was cloned and searched for the presence of candidate genes. 
(b) The minimal physical interval for Bcg was later found to 
include other  genes,  the known functions  of which made 
them very likely candidates for a disease resistance locus. For 
example, the gene family encoding the cell surface receptors 
for  the  key  inflammatory  lymphokine  Ib8  was  recently 
mapped to human 2q35 (IL8RA, IL8RB, IL8RBP; 34, 35) 
and  to  proximal  mouse  1 (36,  37),  within  the NRAMP- 
I/VILI interval (35). (c) The G169D substitution associated 
with the Bcg' phenotype did not constitute an obvious loss 
of function, and a complete polypeptide was expected to be 
produced  in Bcgs mice.  To formally  test  the candidacy of 
Nramp1 as Bcg, we constructed a mouse mutant bearing a 
null allele at Nrampl and analyzed the effect of this mutation 
on the natural resistance to infection with M. b0v/s (BCG). 
These experiments demonstrate that Nramp1 and Bcg are in- 
662  The Ity/Lsh/Bcg Locus deed allelic,  therefore validating our overall experimental 
strategy for positional cloning of Beg. As opposed to sponta- 
neously arising or x ray-induced mutants with an obligatory 
phenotype and having only one or a few alleles, the genetic 
difference at Beg is distributed among "normal" inbred strains 
and is only revealed upon environmental challenge through 
exposure to an infectious agent. As opposed to the former 
situation, in which a chromosomal landmark (deletion, in- 
version, translocation) or obvious non-sense mutation can 
guide the identification of the mutant gene, the latter situa- 
tion may involve  a more subtle change that can only be 
identified in haplotype-mapping studies, extensive nucleotide 
sequencing of the gene from many inbred strains,  and final 
testing of candidate genes in gene-targeting experiments. This 
strategy (identification and study of segregation of allelic vari- 
ants) is likely to prove useful for the identification of genetic 
differences among inbred strains that cause subtle phenotypes 
(behavioral traits), or for the study of more complex and poly- 
genic traits,  such as susceptibility to hypertension, diabetes, 
or neoplasia, where single mutations with obligatory pheno- 
types are rarely, available. 
Nrampl, Beb It),, and Lsh Are Allelic.  Although genetic 
factors have been implicated in resistance to benign and acute 
forms of leishmaniasis (7, 38, 39), the clearest manifestation 
of genetic control is  for  visceral  leishmaniasis  caused  by 
L. donovani. While some mouse strains allow rapid prolifera- 
tion of the parasites in liver, others completely inhibit para- 
site growth. This difference is controlled by the chromosome 
1 locus Lsh (7), and in vitro experiments have shown that 
Lsh is expressed by the mature tissue macrophage (11). In 
the case of murine typhoid caused by S. typhimurium, three 
loci play a key role in susceptibility to infection and response 
to the bacterial  LPS. Inbred strains either rapidly die of an 
overwhelming infection or completely survive challenge with 
a small intravenous inoculum of S. typhimurium. This differ- 
ence is caused by a differential  growth rate of the bacilli in 
RE organs and is controlled by the expression in macrophages 
of the It), locus on chromosome 1 (8, 10, 40). Two additional 
genes have been shown to further modulate S. typhimurium 
resistance  of Ity  r strains.  The  chromosome 4  locus Lps, 
which controls the LPS-induced cytotoxicity and production 
of immunomodulators such as IL-1, CSF, PGE-2 and TNF-cx 
typical  of  activated  macrophages,  is  deficient  (Lps d)  in 
C3H/HeJ (for review see reference 41). In addition, a muta- 
tion in the Btk kinase gene (42, 43) of CBA/N mice (xid; 
44) causes a failure to mount B cell-mediated antibody re- 
sponse against LPS, leading to a progressive and ultimately 
lethal infection. The phenotypic analysis of the Lps and xid 
mutations clearly indicates  that, in addition to the genetic 
advantage conferred by Ity  ~, both efficient LPS-induced mac- 
rophage activation and humoral response are essential for con- 
trolling and ultimately surviving S. typhimurium infection. 
Genetic linkage studies have independently positioned Ity, 
Lsh, and Beg to the same portion of proximal mouse 1 (33). 
Cosegregation analyses in 38 recombinant inbred strains or 
by successive infections in the same backcross mice (26 tested 
for Beg and Lsh)  or by progeny testing (25 families tested 
for Beg and Ity) have failed to detect recombination between 
the three loci (33). However, the limited resolution of these 
analyses (200 meioses analyzed, maximum distance of 1 cM) 
has not allowed the distinguishing between allelism and tight 
linkage. Despite the similarities in phenotypic expression of 
the three loci in RE organs and macrophages, the lack of 
phylogenic links and the different physiopathology caused 
by the three infectious agents have made it difficult to envi- 
sion a pleiotropic mechanism of action. Results from L. dono- 
vani and S. typhimurium infections in Nrampl  null mutants 
(Figs. 5 and 6) demonstrate that Nrampl, Beg, It),, and Lsh 
are indeed the same gene. Therefore, Nrampl  must fulfill a 
biochemical function that is key to the capacity of the mac- 
rophage either to restrict the growth or to actively kill these 
three unrelated microbes. A comparison of the intraceUular 
fate of these three infectious agents may provide some clues 
as to a possible common site of action of Nrampl.  Within 
a few min after phagocytosis, microbes are found included 
within a vacuole called the phagosome. This is followed by 
acidification  of the phagosome to pH 5.5-5 and fusion to 
secondary lysosomes, resulting in further acidification  (pH 
4.5)  and  delivery  of  digestive  enzymes  to  the  vacuole. 
Salmonella, Mycobacterium, and Leishmania are  all  initially 
present in phagosomes but have devised mechanisms to es- 
cape the subsequent cytocidal pathway. Mycobacterium inhibits 
phagosome/lysosome (P/L) fusion (45-47) and completely 
inhibits phagosome acidification by either actively destroying 
the host vacuolar  H+/ATPase or by selectively preventing 
fusion to H +/ATPase positive vesicles (47, 48). The intracel- 
lular fate of Salmonella is more controversial  (49-51),  but a 
strong correlation has been established between intracellular 
survival and inhibition of P/L fusion (50, 52). Salmonella is 
also capable of preventing phagosome acidification, although 
to a lesser extent than Mycobacterium (53). By contrast, Le/sh- 
mania amastigotes inhibit neither P/L fusion nor phagosome 
acidification but can survive and multiply within fused P/L 
(54, 55), possibly through secretion of inhibitory molecules 
such as oxygen radical scavengers (for review see reference 
56). Considering these different survival strategies, it is difficult 
to envision that a late step such as phagosome acidification 
and/or P/L fusion would be a likely site of Nrampl  action. 
Therefore, an earlier step of the parasite-macrophage inter- 
action such as the unfused phagosome stage may be a more 
likely site for Nrampl  action, either through a cytostatic or 
cytocidal  mechanism. 
Nrampl  Function in  the Early  and Late Phases of Infec- 
tion.  Results in Figs. 4-6 dearly establish that Nrampl plays 
a major role in the early phase of infection, which, in the 
case of S. typhimurium infection, is absolutely critical,  since 
animals rapidly die of overwhelming infection in its absence. 
However,  the fact that neither BCG nor L. donovani infec- 
tions are lethal for mice allows investigation of the effect of 
Nrampl disruption on the late "curative" or immune phase 
of infection (Figs. 4 and 5). During this period, infected mac- 
rophages produce II,-1/3 and TNF-cx locally to induce granu- 
loma formation and may act  as  APC  to  activate  CD4 § 
and/or CD8 +  T  cells. Activated T  cells produce a large 
663  Vidal et al. number of cytokines, most importantly IFN-~ and IL-2, which 
mediate the activation of macrophage bactericidal functions 
such as respiratory burst, nitric oxide synthesis, and produc- 
tion of a large number of proteases and other lysosomal en- 
zymes. The key role of IFN-~,-mediated macrophage activa- 
tion in eradication of these infections has been established 
in vivo and in vitro (57-60, 28).  Our results indicate that 
Nrampl ablation impairs neither granuloma formation (Fig. 
3) nor successful microbicidal response in this part of the in- 
fection (Figs. 4 and 5). Since activated macrophages are the 
key effector ceUs of this response, these results suggest that 
Nrarap1 does not play a major role in the elimination of in- 
tracdhilar parasites by activated macrophages. What biochem- 
ical mechanism of Nrarapl action can be proposed to account 
for a key role during the early but not the late phase of infec- 
tion can only be speculated upon. A possible cytocidal func- 
tion mediated by NrampI  could play a major role early in 
infection, but may be redundant and may only form part of 
a number of additional cytocidal mechanisms expressed in 
the late phase after macrophage activation. The observation 
that Nrarapl is constitutively expressed in macrophages but 
is dramatically induced by IFN-qr and LPS treatments is in 
agreement with a function for Nrampl  in both resting and 
activated macrophages (Gros, P., and G. Govoni, unpublished 
observations).  Alternatively, Nrarapl could have a cytostatic 
rather than cytocidal function discernible only early during 
infection, and perhaps creating an intraphagosomal environ- 
ment unfavorable  to parasite  replication.  In  support of a 
cytostatic function for Nrampl are metabolic labding studies 
of Leiskraania amastigotes in infected livers, where differences 
in rates of replication rather than of active elimination were 
associated with the genetic advantage of Lsh  r macrophages 
(61). Irrespective of the model, the study of Nramp1 mutant 
mice clearly suggests a novel mechanism by which macro- 
phages  can  control  replication  of  taxonomically  diverse 
microorganisms independently of the immune system. 
Nramplmp  169  Is  a  Null  Allele.  The  observation  that 
Nrampl a'P  ~69 homozygotes, Nrarapl -/A~p~69  heterozygotes,  or 
Nrampl-/-  homozygotes are equally susceptible to BCG, 
Salmonella, and L. donovani infections (Figs. 4-6) indicates 
that the G169D substitution is not a partial loss of function 
but is rather a null mutation at Nrampl. Nrampl is a novel 
integral membrane protein, the salient predicted features of 
which include I2 TM domains, with 7 of them containing 
at least one charge,  an extracellular  glycosylated  loop, and 
an intracellular consensus transport motif previously described 
in a large number of prokaryotic and eukaryotic membrane 
transporters.  This suggests that Nrampl performs a trans- 
port function in macrophages. We have recently determined 
that (a) Nrarapl is a member of a family of three genes in 
rodents (19, 62) that encode highly conserved polypeptides 
(85% homology) (19); and (b) the Nramp family is extremdy 
weU conserved through evolution, with members identified 
in all animal species tested (75-90% homology), but also in 
distant eukaryotes such as plants, flies, and yeast (50-70% 
homology) (Gros, P., unpublished results). The predicted TM 
domains are the most conserved domains (up to 90%  for 
homologues and 75% for orthologues), including the charged 
amino acids within them, which together suggest a key struc- 
tural and/or functional role for these segments and residues 
in a common mechanism of action of these proteins (e.g., 
stabilization of unstable charges in the lipid bilayer; 63). The 
G169D substitution would replace a small neutral amino add 
by a large residue with a charged side chain within predicted 
TM4 of Nrampl. Considering the high degree of evolutionary 
conservation of both the sequence and charges within TM 
domains, the introduction of an additional charged residue 
within a TM domain would be expected to have severe dele- 
terious effects on protein function. This mutation could affect 
either proper targeting, insertion, or folding of Nrampl within 
the membrane or may interfere with the intimate mechanism 
of transport of Nrampl. 
Haplotype-mapping studies of genealogically and phyloge- 
nedcaUy distant inbred mouse strains have indicated that Beg  s 
strains  share a common chromosome 1 haplotype around 
Nrarapl. This suggests that the NramplasP  169 allele may have 
been present in several founders of the different inbred strains 
and had become randomly fixed in some strains. The persis- 
tence of the potentially deleterious Asp169 aUele in inbred 
mouse strains or even in wild mice can be explained in two 
ways. First, although it is dear that the uncontrolled replica- 
tion of intracellular parasites  in RE organs typical of the 
Asp169 allele may have a dramatic deleterious effect on sur- 
vival of Salmonella infection, it may be counterbalanced by 
positive secondary effects for other types of infection. Indeed, 
Asp169 animals may be more prone to mounting a vigorous 
immune response against certain benign infections, which 
in turn may advantageously cross-protect them against more 
virulent related organisms that may prove lethal to G1y169- 
bearing mice. Alternatively, it is possible that maintaining 
heterozygosity for one of the markers tightly linked to Nrarapl 
and preserved in  the haplotype-defining Bcg'  strains  may 
confer a yet to be identified advantage over strains homozy- 
gous for the Gly169 allele. This advantage may have helped 
preserve the Asp169 in the breeding of inbred strains and may 
even have enabled its survival in the wild. 
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